VIVITE Daily Facial Moisturizer with Sunscreen SPF 30

Dosage form: lotion
Ingredients: octinoxate 75mg in 1mL, octisalate 50mg in 1mL, oxybenzone 60mg in 1mL
Labeler: Allergan, Inc.
NDC Code: 0023-3459

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

VIVITE Daily Facial Moisturizer with Sunscreen SPF 30

Drug Facts

Active ingredients

Octinoxate 7.5%

Octisalate 5%

Oxybenzone 6%

Purpose

Sunscreen

Sunscreen

Sunscreen

Uses
  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use
  • on damaged or broken skin.

When using this product
  • keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if
  • rash occurs.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions
  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • apply to all skin exposed to the sun
  • reapply at least every 2 hours
  • children under 6 months of age: ask a doctor.
  • Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 AM - 2 PM
    • wear long-sleeved shirts, pants, hats, and sunglasses

Other information
  • protect the product in this container from excessive heat and direct sun

  • Store at 68°-77°F (20°-25°C).
  • RETAIN THIS CARTON FOR FUTURE REFERENCE.

Inactive ingredients

Purified Water; Glycolic Acid and Ammonium Glycolate; Glycerin; Pentylene Glycol; Silica; PPG-3 Benzyl Ether Myristate; Cetearyl Alcohol; Glyceryl Stearate; PEG-100 Stearate; Bis-Hydroxyethoxypropyl Dimethicone; Phenoxyethanol; Magnesium Aluminum Silicate; Titanium Dioxide; Iron Oxides; Camellia Oleifera (Green Tea) Leaf Extract; Punica Granatum (Pomegranate) Extract; Glycyrrhiza Glabra (Licorice) Root Extract; Tocopherol; Coco-Glucoside; Xanthan Gum; Butylene Glycol; Disodium EDTA; Steareth-10; Steareth-20; Olea Europaea (Olive) Leaf Extract; Ethylhexylglycerin; Magnesium Ascorbyl Phosphate; and Superoxide Dismutase

Questions or comments?

1.800.377.7790
M-F 6 AM - 4:30 PM Pacific Time
viviteskincare.com

VIVITÉ®

RECOMMENDED
SKIN
CANCER
FOUNDATION

DAILY USE

DAILY FACIAL

MOISTURIZER

WITH SUNSCREEN

BROAD SPECTRUM SPF 30

1.7 fl oz (50 mL)

VIVITÉ®

EXFOLIATES

HYDRATES

PROTECTS

RECOMMENDED
SKIN
CANCER
FOUNDATION

DAILY USE

DAILY FACIAL

MOISTURIZER

WITH SUNSCREEN

BROAD SPECTRUM SPF 30

1.7 fl oz (50 mL)

VIVITE DAILY FACIAL MOISTURIZER WITH SUNSCREEN SPF 30 
octinoxate, octisalate, oxybenzone lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-3459
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
octinoxate (octinoxate) octinoxate75 mg  in 1 mL
octisalate (octisalate) octisalate50 mg  in 1 mL
oxybenzone (oxybenzone) oxybenzone60 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Water 
Glycolic Acid 
Glycerin 
Pentylene Glycol 
Silicon Dioxide 
Cetostearyl Alcohol 
Glyceryl Monostearate 
polyoxyl 100 stearate 
Phenoxyethanol 
Magnesium Aluminum Silicate 
Titanium Dioxide 
Ferric Oxide Red 
Ferrosoferric Oxide 
Ferric Oxide Yellow 
Camellia Oleifera Leaf 
Pomegranate 
Glycyrrhiza Glabra 
Tocopherol 
Coco Glucoside 
Xanthan Gum 
Butylene Glycol 
edetate disodium 
Steareth-10 
Steareth-20 
Olea Europaea Leaf 
Ethylhexylglycerin 
Magnesium Ascorbyl Phosphate 
orgotein 
Packaging
#Item CodePackage Description
1NDC:0023-3459-3612 POUCH (12 POUCH) in 1 CARTON
13 mL in 1 POUCH
2NDC:0023-3459-501 TUBE (1 TUBE) in 1 CARTON
250 mL in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35205/19/2008
Labeler - Allergan, Inc. (144796497)
Establishment
NameAddressID/FEIOperations
Ei Inc.105803274MANUFACTURE

Revised: 11/2011
 
Allergan, Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)